Search Medical Condition
Please enter condition
Please choose location

Allergy Clinical Trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (175) clinical trials

Atopic dermatitis (AD), which is also known as eczema, is a common chronic, relapsing skin condition associated with intense skin itching and rash, which can impact most aspects of everyday life. The exact cause of the disease is not fully known, but it involves an imbalance of the immune system ...

Phase N/A

Summary: A clinical research study of an investigational medication used for individuals with Chronic Obstructive Pulmonary Disease (COPD).

Phase

Summary: A clinical research study for an investigational medication for Chronic Obstructive Pulmonary Disease (COPD).

Phase

Infants/children with cow's milk allergy will take part in 2 double-blinded placebo-controlled food challenges (DBPCFC) of 2 extensively hydrolyzed formulas in random order. If both food challenges are passed, subjects will be asked to consume the Test formula in an at-home open challenge for 7 days.

Phase N/A

Dust Mite Allergy Study - Receive up to $50/visit for expense

Phase

Allergy study for adolescents ages 12 to 17 who are allergic to ragweed. Ragweed is a fall pollen. If you have allergy symptoms such as sneezing, runny or itchy nose, stuffy or congested nose, or itchy and watery eyes starting mid-August that last to the first frost, you could be ...

Phase

Does your child have Ragweeed Allergy or Hayfever? If so, your child may be eligible to participate in a research study of an investigational medication used to treat Allergies in children ages 4-17.

Phase

The objective of this study is to assess the efficacy and safety of 12 months of treatment with 300 IR of STG320 sublingual tablets compared with placebo in adults and adolescents with HDM-associated allergic rhinitis.

Phase

If your child has a ragweed allergy, he/she may be eligible to participate in a clinical research study to evaluate the effectiveness and safety of an investigational sub-lingual immunotherapy tablet.

Phase N/A